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Abstract
Trophic coupling between cerebral endothelium and their neighboring cells is required for the development and
maintenance of blood-brain barrier (BBB) function. Here we report that oligodendrocyte precursor cells (OPCs) secrete
soluble factor TGF-b1 to support BBB integrity. Firstly, we prepared conditioned media from OPC cultures and added them
to cerebral endothelial cultures. Our pharmacological experiments showed that OPC-conditioned media increased
expressions of tight-junction proteins and decreased in vitro BBB permeability by activating TGB-b-receptor-MEK/ERK
signaling pathway. Secondly, our immuno-electron microscopic observation revealed that in neonatal mouse brains, OPCs
attach to cerebral endothelial cells via basal lamina. And finally, we developed a novel transgenic mouse line that TGF-b1i s
knocked down specifically in OPCs. Neonates of these OPC-specific TGF-b1 deficient mice (OPC-specific TGF-b1 partial KO
mice: Pdgfra
Cre/Tgfb1
flox/wt mice or OPC-specific TGF-b1 total KO mice: Pdgfra
Cre/Tgfb1
flox/flox mice) exhibited cerebral
hemorrhage and loss of BBB function. Taken together, our current study demonstrates that OPCs increase BBB tightness by
upregulating tight junction proteins via TGF-b signaling. Although astrocytes and pericytes are well-known regulators of
BBB maturation and maintenance, these findings indicate that OPCs also play a pivotal role in promoting BBB integrity.
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Introduction
The concept of the neurovascular unit is now relatively well
accepted. The neurovascular unit emphasizes that cell-cell
interaction between neuronal, glial, and vascular elements is
critical for brain function [1]. One of the most documented non-
cell autonomous phenomena in the neurovascular unit is the
blood-brain barrier (BBB). BBB is an essential property of brain
blood vessels that allow the brain to maintain its highly specialized
microenvironment and homeostasis [2,3]. BBB function is
sustained by trophic coupling between cerebral endothelium and
neighboring cells, such as pericytes and astrocytes [4,5,6].
Trophic coupling of endothelium-pericyte-astrocyte tightly
regulates BBB formation and maturation [7]. According to
current understanding, pericytes are recruited to cerebral endo-
thelial cells to initiate BBB properties during embryogenesis.
Cerebral endothelial cells release platelet-derived growth factor
(PDGF) to recruit pericytes, which express PDGF-receptor-b [8].
Adhesion between cerebral endothelial cells and pericytes is
mediated by transforming growth factor b (TGF-b) secreted from
the cell types in paracrine and autocrine manners. TGF-b
stimulates the production of extracellular matrix in pericytes,
which then induces the upregulation of cadherin-2 in cerebral
endothelial cells [5,9]. After pericytes are set in place, astrocytes
are subsequently recruited to enhance BBB tightness during
development [8] and maintain BBB function [10]. Angiopoietin 1
and Sonic hedgehog secreted from astrocytes increase tight
junction protein expression and barrier function of cerebral
endothelial cells [11,12]. Astrocytes also produce apolipoprotein E
to promote BBB maturation through lipoprotein receptor-related
protein in cerebral endothelial cells [13,14].
However, besides astrocytes and pericytes, other types of brain
cells also exist in the brain. Our recent studies have proposed that
oligodendrocyte lineage cells may communicate with cerebral
PLOS ONE | www.plosone.org 1 July 2014 | Volume 9 | Issue 7 | e103174endothelial cells via the exchange of soluble factors [15,16]. For
example, trophic factors including fibroblast growth factor -2
(FGF-2) and brain-derived neurotrphic factor (BDNF) from
cerebral endothelial cells may promote the proliferation and
survival of oligodendrocyte precursor cells (OPCs) even under
pathologic conditions [17]. In addition, cerebral endothelial cells
may also support OPC migration via secreting vascular endothelial
growth factor [18]. In turn, oligodendrocyte lineage cells may
participate in vascular dysfunction and repair after white matter
injury [15,19]. Since oligodendrocyte precursor cells can act as a
critical source of trophic factors [20], it may be possible that OPCs
also help regulate BBB integrity. Therefore, in this study, we
explore the hypothesis that trophic coupling between cerebral
endothelium and OPCs is fundamentally BBB-protective.
Materials and Methods
Cell Culture
All experiments were reviewed and approved by a Subcommit-
tee for Research Animal Care of the Massachusetts General
Hospital IACUC (Institutional Animal Care and Use Committee)
and all these institutionally-approved animal protocols are
consistent with the NIH Guide for the Care and Use of Laboratory
Animals. OPCs were prepared from cerebral cortices of 1–2 day
old Sprague-Dawley (SD) rats. Dissociated cortex cells were plated
in poly-d-lysine-coated flasks, and culture in Dulbecco’s Modified
Eagle’s medium containing 20% fetal bovine serum and 1%
penicillin/streptomycin. After the cells were confluent, the flasks
were shaken for 1 hour on an orbital shaker (220 rpm) at 37uCt o
remove microglia. The medium was changed with a new medium
and shaken overnight. The medium was then collected and plated
on non-coated tissue culture dishes for 1 hour at 37uC to eliminate
possible contamination by astrocytes and microglia. The non-
adherent cells were collected and cultured in Neurobasal Media
containing glutamine, 1% penicillin/streptomycin, 10 ng/mL
PDGF-AA, 10 ng/mL FGF-2, and 2% B27 supplement onto
poly-dl-ornithine-coated plates. Rat brain microendothelial cell
lines (RBE.4) were cultured in EBM-2 containing EGM-2MV
Single Quots kit onto collagen-coated flasks.
Preparation OPC conditioned medium
OPC cultures were washed with PBS and maintained in
Neurobasal media for 24 hours. Culture medium was then
collected and centrifuged at 10,000 g for 5 min at 4uC to remove
cells and debris. The OPC conditioned medium was stored at
280uC until use.
Immunocytochemistry
After cells were confluent, they were washed with ice-cold PBS
(pH 7.4), followed by 4% PFA for 15 min. After being further
washed three times in PBS, they were incubated with 3% BSA in
PBS for 1 hour. Cells were then incubated with primary antibody
against ZO-1 (1:200, Invitrogen) or Smad2/3 (1:200, Santacruz) at
4uC overnight. After washing with PBS, they were incubated with
secondary antibodies conjugated with fluorescein isothiocyanate
for 1 hour at room temperature. Finally, nuclei were counter-
stained with DAPI. Image was analyzed with a fluorescence
microscope (Nikon) interfaced with a digital charge-coupled device
camera and an image analysis system.
In vitro endothelial permeability assay
Permeability across the endothelial cell monolayer was
measured by using type I collagen-coated transwell units
(6.5 mm diameter, 3.0 mm pore size polycarbonate filter, Corn-
ing). After RBE.4 cells became confluent on the transwell, the cells
were treated with OPC conditioned media for 24 hours. Then,
fluorescein isothiocyanate-labeled dextran (molecular weight,
40,000) was added to the upper chamber. After incubation for
10 min, 100 ml of sample from the lower compartment was
measured for fluorescence at 620 nm when excited at 590 nm
with a spectrophotometer.
Cell viability assay
To ensure that OPC-conditioned media has no effect on
endothelial cells survival, cell viability was quantified by lactate
dehydrogenase (LDH) release with the use of the LDH assays kit
(Roche).
Immunohistochemistry
Mouse brains were taken out from 0–1 day old pups. After
perfusion with PBS (pH 7.4), brains were quickly frozen using
powdered dry ice. Coronal sections of 16-mm thicknesses were cut
on cryostat at 220uC and collected on glass slides. Sections were
fixed by 4% PFA, and rinsed three times in PBS (pH 7.4). After
blocking with 3% BSA, sections were incubated at 4uC overnight
in PBS/0.1% Tween/0.3% BSA solution containing primary
antibodies –anti-NG2 (a marker for OPC, 1:100, Millipore), anti-
PDGF-receptor-a [CD140a] (a marker for OPC, 1:100, Santa-
cruz), anti-PDGF-receptor-b [CD140b] (a marker for pericyte,
1:100, eBioscience), anti-GFAP (a marker for astrocyte, 1:200, BD
Pharmingen), anti-CD31 (a marker for endothelial cell, 1:100, BD
Pharmingen), anti-Cre (1:100, Millipore), and anti-TGF-b (1:100,
Abcam). Then sections were washed and incubated with
secondary antibodies with fluorescence conjugations at room
temperature for 1 hr. For lectin staining, sections were incubated
in fluorescein labeled Lycopersicon Esculentum (Tomato) Lectin
(1:200, Vector Laboratories) at room temperature for 15 min.
Subsequently, sections were washed and the slides were covered
with VECTASHIELD mounting medium with DAPI (H-1200
from Vector Laboratories). Immunostaining was analyzed with
confocal microscopy or fluorescence microscope (Nikon) interfaced
with a digital charge-coupled device camera and an image analysis
system.
Immuno-Electron Microscopy
For electron microscopic investigation of PDGF-receptor-a,
postnatal day 1–2 SD rats were perfused trans-cardially with 0.1%
glutaraldehyde-4% PFA fixative, and brains were immersed in the
4% PFA at 4uC for 5 h and sectioned at a thickness of 50 mm with
a microslicer (Dosaka EM). After blocking with 10% NGS,
sections were incubated with anti- PDGF-receptor-a (1:100, Santa
Cruz, CA, USA) at 4uC overnight. They were then incubated with
biotinylated anti-rabbit IgG (1:200), Vectastain ABC reagent
(Vector Laboratories, Inc., Burlingame, CA) according to the
manufactur’s procedures and visualized by 3, 39-diaminobenzidine
tetrahydrochloride-H2O2 solution. After the DAB reaction,
sections were post-fixed with 1% OsO4 for 1 h, dehydrated, and
flat-embedded on siliconized glass slides in Epon. Ultrathin
sections from corpus callosum were stained with 2% uranyl
acetate and lead citrate. Electron micrographs were taken at 80 kV
on a JEM-1200EX electron microscope.
Breeding and Genotyping of Mutant mice
Pdgfra
Cre mice and Tgfb1
flox/flox mice were purchased from
Jackson Laboratories. Pdgfra
Cre mice with a C57BL/6 genetic
background are a strain of mice expressing Cre recombinase
under the control of a Pdgfra (the gene for platelet-derived growth
OPCs and Blood-Brain Barrier
PLOS ONE | www.plosone.org 2 July 2014 | Volume 9 | Issue 7 | e103174Figure 1. OPC-derived TGF-b1 and BBB integrity in vitro. A. We prepared conditioned media from OPCs (OPC-CM), and then added them to
cerebral endothelial RBE.4 cells. B. OPC-CM increased in vitro BBB tightness (i.e. decreased permeability of endothelial monolayer), and the TGF-b-
receptor signaling inhibitor SB431542 (10 mM) cancelled the effects of OPC-CM. Mean 6 SD of n=3. *p,0.05 vs control (OPC-CM: 2, SB431542: 2),
#P,0.05 vs OPC-CM only (OPC-CM: +, SB431542: 2). C–D. Correspondingly, OPC-CM increased the expressions of tight junction proteins, and once
again, SB431542 (10 mM) cancelled the effects of OPC-CM. E. Immunostaining confirmed that our cultured rat OPCs produced TGF-b1. PDGF-R-a
staining was used to confirm the purity of our OPC cultures. F. LDH assay showed that the TGF-b receptor inhibitor SB431542 (10 mM) did not affect
endothelial viability. Mean 6 SD of n=3.
doi:10.1371/journal.pone.0103174.g001
OPCs and Blood-Brain Barrier
PLOS ONE | www.plosone.org 3 July 2014 | Volume 9 | Issue 7 | e103174Figure 2. MEK/ERK pathway mediates the roles of OPC-derived TGF-b1 in enhancing in vitro BBB integrity. A. OPC-CM treatment
(30 min) increased the levels of phospho-ERK1/2 in cerebral endothelial RBE.4 cells, and both the TGF-b receptor inhibitor SB431542 (10 mM) and a
MEK/ERK inhibitor U0126 (10 mM) blocked the ERK1/2 phosphorylation by OPC-CM. B–D. U0126 cancelled the supporting effects of OPC-CM on the
BBB tightness in our in vitro model. Mean + SD of n=3, *p,0.05 vs control (OPC-CM: 2, U0126: 2), #P,0.05 vs OPC-CM only (OPC-CM: +, U0126: 2).
E. LDH assay showed that the MEK/ERK inhibitor U0126 (10 mM) did not affect endothelial viability. Mean 6 SD of n=3.
doi:10.1371/journal.pone.0103174.g002
OPCs and Blood-Brain Barrier
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flox/flox mice
in a mixed 1296C57BL/6 genetic background are a strain of mice
carrying a loxP-flanked Tgfb1 gene. First, Pdgfra
Cre mice were
crossed with Tgf-beta1lox/lox mice. Subsequently, Pdgfra
Cre/
Tgfb1
flox/wt double heterozygotes were bred to Tgfb1
flox/flox mice.
Genotyping was done by PCR analysis using genomic DNA from
mouse tail biopsies. Genotyping primers for the detection of
Pdgfra
Cre transgene (product size ,100 bp) were 59-GCG GTC
TGG CAG TAA AAA CTA TC-39 (forward) and 59-GTG AAA
CAG CAT TGC TGT CAC TT-39 (reverse). Genotyping primers
for the detection of Tgfb1 wild-type (product size 216 bp) and
loxP-flanked alleles (277 bp) were 59-AAG ACC TGG GTT GGA
AGT G-39 (forward) and 59-CTT CTC CGT TTC TCT GTC
ACC CTA T-39 (reverse).
Western Blotting
Lysates from the corpus callosum region were prepared in Pro-
PREPTM Protein Extraction Solution (Boca Scientific). Samples
with equal volumes of SDS sample buffer (Novex) and 2-ME were
heated at 95uC for 5 min, then each sample (20 mg per lane) was
loaded onto 4–20% Tris–glycine gels. After electrophoresis and
transferring to polyvinylidene difluoride membranes (Novex), the
membranes were blocked in Brockace (AbD Serotec) for 60 min at
room temperature. Membranes were then incubated overnight at
4uC with anti-ZO-1 antibody (1:1000, Invitrogen), anti-occludin
antibody (1:1000, Abcam), anti-claudin5 (1:1000, Abcam), anti-
ERK1/2 (1:1000, Cell Signaling), anti-phospho-ERK1/2 (1:000,
Cell Signaling) or anti-b-actin antibody (1:5000, Sigma Aldrich)
followed by incubation with peroxidase-conjugated secondary
antibodies and visualization by enhanced chemiluminescence
(Amersham).
IgG staining
Mouse brains were taken out after perfusion with 0.9% saline
and quickly frozen using powdered dry ice. Coronal sections of
20mm thickness were cut on cryostat at 220uC and collected on
glass slides. Sections were fixed by 4% PFA and rinsed 3 times in
PBS (pH 7.4). Subsequently, the sections were incubated in 3%
H2O2, followed by blocking with 10% Brockace (AbD serotec) in
PBS. Then the sections were incubated overnight at 4uC with
antibody against donkey anti-mouse IgG (1:300; Jackson Im-
munoresearch Laboratories). Immunoreactivity was visualized
using fluorescence-conjugated streptavidin. Staining was analyzed
with a fluorescence microscope (Nikon) interfaced with a digital
charge-coupled device camera and an image analysis system. The
acquired images were processed using Adobe Photoshop (version
7, Adobe System). RGB images were converted to 8-bit grayscale
images. Based on an analysis of pixel fluorescence intensities,
which ranged from 0 to 255, specific staining was distinguished
from background by using a threshold value of 40–50. Area
densities of structures stained with IgG were calculated as the
proportion of pixels having a fluorescence intensity value equal to
or greater than the threshold. Fields in the cortex were examined
and IgG staining area was calculated by determining the number
of pixels with positive staining per microscope field: this ratio was
expressed as % area.
Statistical Analysis
Statistical significance was evaluated using the unpaired t-test to
compare differences between the two groups and a one-way
ANOVA followed by Tukey’s honestly significant difference test
for multiple comparisons. Data are expressed as mean 6 S.D. A p-
value of ,0.05 was considered statistically significant.
Results
We prepared primary OPC cultures from rat neonatal brain
cortex. When conditioned media were collected from rat OPC
cultures and added to rat cerebral endothelial RBE.4 cells, the
dextran permeability of these endothelial monolayers was signif-
icantly decreased (Figure 1A–B). This response was accompanied
by an upregulation in the endothelial tight junction proteins ZO-1,
occludin and claudin-5 (Figure 1C–D). Tight junctions are known
to be regulated by TGF-b1 [21]. So next we examined the role of
TGF-b1 in our model system. OPCs expressed TGF-b1 in culture
(Figure 1E), and co-treatment with the TGF-b receptor inhibitor
SB431542 prevented OPC conditioned media from upregulating
tight junction proteins and decreasing endothelial permeability
(Figure 1B–E). The LDH assay showed that the SB431542
treatment did not affect the endothelial viability in our cell culture
system (Figure 1F).
Our pharmacological experiments also identified that MEK/
ERK pathway mediates the enhancement of in vitro endothelial
tightness by OPC-derived TGF-b1. Conditioned media from
OPC cultures increased the level of ERK1/2 phosphorylation,
which was blocked by co-treatment with SB431542 or the MEK/
ERK inhibitor U0126 (Figure 2A). Correspondingly, U0126
cancelled the supportive effects of OPC-conditioned media on
cerebral endothelial cells - endothelial permeability (Figure 2B)
and tight junction protein expression (Figure 2C–D). Again, the
LDH assay confirmed that the U0126 treatment did not induce
overt cell death in the endothelial cultures (Figure 2E). Taken
together, these data suggest that OPCs secrete TGF-b1 to support
cerebral endothelial barrier function in vitro.
Since OPCs can increase barrier tightness in cerebral endothe-
lial cell cultures, we then asked whether this phenomenon may
occur in vivo. Immunostaining of brain sections from postnatal
mice showed that micro-vessels (CD31, red color) were wrapped
with fine processes emanating from OPCs (PDGF-receptor-a,
green color) (Figure 3A). Triple staining with lectin (blue color,
endothelial cell marker), PDGF-receptor-b (red color, pericyte
marker), and PDGF-receptor-a (green color, OPC marker)
showed that at least around the blood vessels, PDGF-receptor-a
was indeed a specific OPC marker, i.e. there was no overlap
between PDGF-receptor-b (pericytes) and PDGF-receptor-a
(OPCs) (Figure 3B). To further confirm that OPCs are closely
located to cerebral endothelium, we then conducted immuno-
electron microscopic analysis using anti-PDGF-receptor-a anti-
body. Again, PDGF-receptor-a-positive OPCs were observed to
attach to cerebral endothelium via basal lamina structures
(Figure 3C).
Finally, we developed a line of transgenic mice with OPC-
specific TGF-b1 deficiency using Pdgfra
Cre mice that express Cre
recombinase under the control of a Pdgfra (the gene for platelet-
derived growth factor receptor-alpha) genomic DNA fragment.
Cre staining confirmed that in the Pdgfra
Cre mice, Cre expressions
were restricted to PDGF-R-a-positive OPCs at post-natal day 0
(Figure 4A). OPC-specific TGF-b1 deficient mice were generated
by crossing Pdgfra
Cre mice with Tgfb1
flox/flox mice that carry a
loxP-flanked Tgfb1 gene. Immunostaining confirmed that TGF-
b1 expression in OPCs was reduced or absent in Pdgfra
Cre/
Tgfb1
flox/wt mice (OPC-specific TGF-b1 partial knockout (KO)
mice) or Pdgfra
Cre/Tgfb1
flox/flox mice (OPC-specific TGF-b1 total
KO mice), respectively (Figure 4B). TGF-b1 expression was not
affected in other vascular-related brain cells, such as cerebral
endothelium, astrocytes or pericytes (Figure 5). Importantly,
compared to control mice, OPC-specific TGF-b1 total KO mice
showed massive cerebral hemorrhage, and even OPC-specific
OPCs and Blood-Brain Barrier
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extent at post-natal day 0–1 (Figure 6A). Staining for IgG leakage
demonstrated that significant leakage of this large serum protein
was observed in the OPC-specific TGF-b1 deficient mice
(Figure 6B–C). Similar to the findings from our in vitro study,
the tight junction protein ZO-1 was degraded in the transgenic
mice (Figure 6D), suggesting that OPC-derived TGF-b1 plays an
important role in BBB integrity.
Discussion
Our data demonstrate that OPCs are an important source of
TGF-b1 that supports BBB integrity during development. OPC-
derived TGF-b1 activates the MEK/ERK pathway in cerebral
endothelium via TGF-b receptor, and the signaling cascade
eventually increases the expression levels of tight-junction proteins
to promote the BBB integrity. TGF-b1 is well known to modulate
blood vessel development and maturation. For example, TGF-b1
KO mice had a severe deficiency in formation and maintenance of
vasculatures, and TGF-b-receptor KO mice exhibited defective
yolk sac vasculogenesis [22,23,24]. In addition, past cell culture
studies have shown that astrocyte-endothelium or pericyte-
endothelium trophic coupling induce the activation of TGF-b1
signaling, which is required for vascular barrier function [25,26].
Our current study may expand the roles of TGF-b signaling in
vascular system; i.e. OPCs can secrete TGF-b1 to support/
enhance BBB tightness via a MEK/ERK signaling pathway
(Figure 7).
Our present findings are significant because they imply that
OPCs are not merely precursor cells for oligodendrocytes. Instead,
OPCs might additionally participate in balancing brain homeo-
stasis by secreting soluble factors. During development, progenitor
Figure 3. OPC-endothelium interaction. A. Immunostaining showed that some OPCs (green: PDGF-R-a) are located closely to cerebral
endothelium (red: CD31) in mice at post-natal day 0–1. Scale bar=50 mm. B. Triple staining showed that there is little overlap between PDGF-R-a and
PDGF-R-b. Scale bar=10 mm. C. Electron micrography also confirmed that OPCs attached directly to the basal lamina (Bl) of endothelial cells in corpus
callosum. arrows: PDGF-R-a positive signals, Scale bar=1 mm.
doi:10.1371/journal.pone.0103174.g003
Figure 4. OPC-specific TGF-b1 deficient mice. A. Immunostaining showed that in Pdgfra
Cre mice, Cre recombinase expression was observed
only in PDGF-R-a positive cells (e.g. OPCs) at post-natal day 0. Scale bar=25 mm. B. Compared to wild-type mice (Pdgfra
wt/Tgfb1
flox/wt), TGF-b1
expression in OPCs at post-natal day 0 was reduced or absent in OPC-specific TGF-b1 partial KO mice (Pdgfra
Cre/Tgfb1
flox/wt mice) or OPC-specific TGF-
b1 total KO mice (Pdgfra
Cre/Tgfb1
flox/flox mice), respectively. Arrows indicate PDGF-R-a positive cells (e.g. OPCs).
doi:10.1371/journal.pone.0103174.g004
OPCs and Blood-Brain Barrier
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for new oligodendrocytes and give rise to young migrating OPCs.
These newborn cells move out of the SVZ into the corpus
callosum, striatum, and fimbria fornix and then differentiate into
myelinated oligodendrocytes. Beyond this expected role in brain
development, our current study suggests a novel role for OPCs
that they secrete soluble factors to regulate neighboring microen-
vironments. While little is known in the case of OPCs, mature
oligodendrocytes are now well accepted to act as growth factor
providers for neighboring cells [20,27]. For example, oligoden-
drocytes synthesize defined growth factors and provide trophic
signals to nearby neurons. Previous studies show that oligoden-
drocyte-derived trophic factors, such as insulin-like growth factor-1
and glial cell derived neurotrophic factor, promote neuronal
survival and axonal outgrowth in vitro [28]. Moreover, oligoden-
drocytes may serve as a principal metabolic supplier of lactate,
Figure 5. TGF-b1 expression in vascular-related brain cells. Immunostaining confirmed no clear differences in TGF-b1 expression in (A)
cerebral endothelium assessed by CD31 staining, (B) astrocytes assessed by GFAP staining, and (C) pericytes assessed by PDGF-R-b staining at post-
natal day 0 in the OPC-specific TGF-b1 deficient mice (OPC-specific TGF-b1 partial KO mice: Pdgfra
Cre/Tgfb1
flox/wt mice or OPC-specific TGF-b1 total KO
mice: Pdgfra
Cre/Tgfb1
flox/flox mice).
doi:10.1371/journal.pone.0103174.g005
OPCs and Blood-Brain Barrier
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ylate transporter 1 [29]. Therefore, similar to mature oligoden-
drocytes, OPCs might also be a growth factor provider for
supporting functions of other cell types.
In relation to the notion that OPCs would nourish neighboring
cells, our study is consistent with the emerging idea of the concept
of neurovascular unit. The neurovascular unit was proposed to
understand pathophysiologic responses after stroke and other CNS
diseases. This concept emphasized that brain function and
dysfunction arise from integrated interactions between neurons,
astrocytes, and vascular compartments. Neurovascular responses
after injury underlie a transition from acute injury to delayed
repair as the brains initiate endogenous angiogenesis and
neurogenesis [30,31,32,33]. It is now recognized that in gray
matter, angiogenic and neurogenic responses are tightly co-
regulated after brain injury, comprising cell-cell signaling within
the neurovascular niche [34,35]. The idea of the neurovascular
niche primarily guide research in cell-cell trophic coupling in gray
matter. But those interactions are likely to be important in white
matter as well. With a guide from the idea of neurovascular unit,
we have proposed that an analogous oligovascular niche may also
exist and support white matter homeostasis through the cell-cell
interaction between cerebral endothelium and oligodendrocytes
[20,36]. Our current findings may provide a novel insight for the
roles of oligovascular niche; i.e. in the microenvironment between
OPCs and endothelial cells, OPC-derived TGF-b1 helps endo-
thelial cells promote BBB integrity.
Our current study demonstrates the novel roles of OPCs in the
CNS vascular system. Nevertheless, there are a few issues that
warrant further studies. First, we only focused on the OPC-BBB
interaction at post-natal day 0–1, but OPCs also exist in the
embryonic stage. How OPCs contribute to the entire temporal
spectrum of BBB development, and whether OPCs interact with
other glia such as astrocytes and pericytes during BBB maturation
should be examined in future studies. Second, OPCs may secrete
several soluble factors other than TGF-b1 [20,27]. Hence,
examining the mechanisms of other OPC-endothelium mediators
will be very important. Third, we used both male and female pups
for preparing OPC cultures. Since we mixed all the brains from
one litter during the OPC preparing procedure, our OPC cultures
were from approximately 50% male and 50% female OPCs. But
potential sex differences in OPC function are important. Previous
papers reported that neuron cultures from female rats showed
more resistance to stresses than ones from male [37,38,39]. But sex
differences in OPC function are still mostly unknown. Therefore,
future studies should carefully examine the differences between
Figure 6. OPC-derived TGF-b1 and BBB integrity in vivo. A. The OPC-specific TGF-b1 partial or total KO mice showed hemorrhage at post-
natal day 0–1. B–C. IgG staining showed that in the OPC-specific TGF-b1 partial or total KO mice, IgG was leaked from blood vessels into brain
parenchyma. Green: IgG, Orange: Lectin (endothelial marker), scale bar=100 mm. Mean + SD of n=4–5, *p,0.05 vs control group. D. The OPC-
specific TGF-b1 deficient mice exhibited BBB leakages (IgG staining) and aberrant ZO-1 structures.
doi:10.1371/journal.pone.0103174.g006
Figure 7. Proposed model for OPC-BBB interaction. Trophic coupling between OPCs and cerebral endothelium may play an important role in
the BBB function. TGF-b1 may mediate the cell-cell interaction; i.e. OPCs secrete TGF-b1, which then binds to its receptor, followed by activating MEK/
ERK pathway to increase the BBB tightness.
doi:10.1371/journal.pone.0103174.g007
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current data of OPC effects on the BBB were obtained in
immature systems, and therefore, our findings of endothelium-
OPC interaction are limited to the BBB development and
maturation period. But our data may show some implications
for mature brain pathology/pathophysiology. OPCs comprises
about 5% of cells in the adult brain [40] and these populations of
OPCs may contribute to white matter homeostasis [41,42].
Therefore, further effects on BBB function in fully mature brains
require more careful analysis in the future. OPCs are known to be
vital repair cells for white matter, and BBB dysfunction is an
important part of white matter dysfunction in a wide range of CNS
diseases [43,44]. Hence, investigating the mechanisms of OPC-
BBB interaction in adult brain may help identify novel therapeutic
approaches for protecting vascular homeostasis in white matter
[45,46].
Gliovascular signaling is essential for BBB development and
maturation. Our study suggests that besides astrocytes and
pericytes, OPCs can surprisingly play an important role in
supporting BBB function and homeostasis.
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